Advertisement
Canada markets open in 5 hours
  • S&P/TSX

    22,107.08
    +194.56 (+0.89%)
     
  • S&P 500

    5,248.49
    +44.91 (+0.86%)
     
  • DOW

    39,760.08
    +477.75 (+1.22%)
     
  • CAD/USD

    0.7353
    -0.0020 (-0.27%)
     
  • CRUDE OIL

    81.80
    +0.45 (+0.55%)
     
  • Bitcoin CAD

    95,963.53
    +929.89 (+0.98%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,213.70
    +1.00 (+0.05%)
     
  • RUSSELL 2000

    2,114.35
    +44.19 (+2.13%)
     
  • 10-Yr Bond

    4.1960
    0.0000 (0.00%)
     
  • NASDAQ futures

    18,490.50
    -13.25 (-0.07%)
     
  • VOLATILITY

    12.97
    +0.19 (+1.49%)
     
  • FTSE

    7,952.82
    +20.84 (+0.26%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6810
    +0.0005 (+0.07%)
     

Valeant is getting beat up again

Pharmaceutical firm Valeant's stock continued its sell off Monday morning with the stock opening down over 5%.

The stock started falling on September 18, when lawmakers started taking action against companies that gouge the prices of prescription drugs. Since then, it's lost a quarter of its value.

VRX stock one month
VRX stock one month

(Yahoo Finance)

Washington's interest was peaked when the world found out about Martin Shkreli, a hedge fund manager who purchased a prescription drug and jacked up the price 5,000%.

That started a conversation about pharmaceutical firms that engage in the same behavior, and Valeant — a Wall Street darling with a connection to hedge fund manager Bill Ackman — was pinpointed as one of the worst offenders.

ADVERTISEMENT

Last week, short selling firm Citron research released a note about Valeant with a table listing all the drugs the company purchased and their price increases:

valeant drug gouge chart
valeant drug gouge chart

(Citron Research)

NOW WATCH: We got our hands on Donald Trump's failed 1989 board game and it's bizarre



More From Business Insider